“SERENA WILLIAMS’ WEIGHT LOSS REVEALED!: “Serena Williams opens up on turning to weight loss medication, losing 31 LBS (14KG)” –

Serena Williams, the 23‑time Grand Slam champion, just opened up about a chapter of her life that’s resonated with fans worldwide: she’s lost 31 pounds (about 14 kg) with the help of a prescription GLP‑1 medication called Zepbound (tirzepatide). The news broke in a candid interview with _People_ and a sleek Instagram post, and it’s already sparking conversation about body image, motherhood, and the role of weight‑loss drugs in modern health routines.

“Why She Turned to Medication”

After the births of her daughters, Olympia (2017) and Adira (2023), Serena found that the rigorous training and clean‑eating habits that once defined her career weren’t enough to shift the scale. “I tried everything—running, biking, stair‑climbing, even playing tennis professionally—but my body wasn’t responding the way it used to,” she told NBC’s _Today_ show .¹ The plateau left her feeling frustrated, especially after years of never “taking shortcuts” in her sport.

Enter Zepbound, a GLP‑1 receptor agonist that mimics a natural hormone to curb appetite and slow stomach emptying. The drug, originally designed for type‑2 diabetes, has become a game‑changer for weight management, helping users lose up to 20 % of their body weight in clinical trials.

“The Journey in Numbers”

– *Weight lost:* ~31 lb (14 kg)
– *Timeframe:* Roughly eight months of treatment
– *Method:* Weekly injections of Zepbound, combined with her usual high‑intensity workouts and a protein‑rich diet (she’s a fan of beans) ³ ⁴

Serena says the medication acted as a “power tool” that amplified the effects of her already disciplined lifestyle. “It didn’t replace my workouts; it just made them work better,” she explained.

*What the Experts Say”

Dr. Scott Isaacs, president of the American Association of Clinical Endocrinology, notes that tirzepatide targets both GLP‑1 and GIP receptors, delivering greater weight loss than earlier GLP‑1 drugs like semaglutide . He emphasizes that the medication works best when paired with regular exercise and a balanced, low‑calorie diet, and that long‑term use is usually required to keep the weight off.

“Impact Beyond the Scale”

Serena’s candidness is doing more than just sharing a transformation—it’s reshaping the conversation around postpartum bodies and weight‑loss meds. She’s using her platform to normalize the idea that seeking medical help for weight issues is no different from treating diabetes or hypertension. “Choosing to treat obesity is a choice for health, not a sign of weakness,” she said.

Fans have responded with a mix of admiration and relief, grateful that a global icon is shining a light on a topic that’s often shrouded in stigma. The discussion is also prompting more people to ask their doctors about GLP‑1 options, especially those who’ve struggled with stubborn weight after pregnancy.
_Bottom Line_

Serena Williams’ 31‑pound loss isn’t just a headline—it’s a real‑life example of how modern medicine, when combined with disciplined nutrition and exercise, can help people break through weight‑loss plateaus. Her openness is breaking barriers, encouraging a healthier, more compassionate dialogue about body image and the tools available to support it.